Can Psychedelics Treat Alzheimer’s Disease?

Researchers argue that the microbiological action of psychedelics may help fight brain-based symptoms in early Alzheimer’s patients.

Evan Lewis-Healey
3 min readDec 27, 2021
Neuronal axons from an Alzheimer’s mouse, retrieved from Wikimedia Commons

An aging population is a double-edged sword. On one hand, people living longer demonstrates that modern medicine is working and people are generally living healthier lives. On the other hand, an aging population means that conditions like Alzheimer’s disease are more widespread than ever before.

But the psychedelic movement offers renewed hope.

A recent paper published in Current Topics in Behavioural Sciences highlights that psychedelics may be used as a tool to fight this degenerative brain disease, and paves the way for a new line of research, where psychedelics can be used to treat specific symptoms of this type of dementia.

In the United States, more than five million adults are living with Alzheimer’s, with the figure expected to triple in the next 30 years. This is a rapid cause for concern — there is, of course, no magic bullet for the treatment of Alzheimer’s.

However, Dr. Albert Garcia-Romeu and his colleagues from Johns Hopkins University, argue that psychedelics could soften the blow of this horrendous condition on the individual and…



Evan Lewis-Healey

PhD candidate at Cambridge University. Studying the cognitive neuroscience of altered states of consciousness.